Cartesian Therapeutics, Inc.RNACNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank73
3Y CAGR+252.2%
5Y CAGR+23.9%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+252.2%/yr
vs -64.2%/yr prior
5Y CAGR
+23.9%/yr
Recent acceleration
Acceleration
+316.4pp
Accelerating
Percentile
P73
Within normal range
vs 5Y Ago
2.9x
Strong expansion
Streak
3 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 26.74 | +292.2% |
| 2024 | 6.82 | +396.8% |
| 2023 | 1.37 | +124.3% |
| 2022 | 0.61 | -77.5% |
| 2021 | 2.72 | -70.3% |
| 2020 | 9.17 | +214.9% |
| 2019 | 2.91 | -92.2% |
| 2018 | 37.22 | -93.4% |
| 2017 | 566.76 | +4332.0% |
| 2016 | 12.79 | - |